In addition, the knockdown of DUXAP8 significantly represses epithelial-mesenchymal transition (EMT) in lung cancer and hepatocellular carcinoma.27,28 However, the biological functions of DUXAP8 in BC have not been elucidated. This evidence concerns the gene DUXAP8 and breast cancer.